Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey.

Brufsky AM, Ormerod C, Bell Dickson R, Citron ML.

Breast J. 2017 Jan;23(1):17-25. doi: 10.1111/tbj.12675. Epub 2016 Sep 13.

PMID:
27623209
2.

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).

Liu MC, Pitcher BN, Mardis ER, Davies SR, Friedman PN, Snider JE, Vickery TL, Reed JP, DeSchryver K, Singh B, Gradishar WJ, Perez EA, Martino S, Citron ML, Norton L, Winer EP, Hudis CA, Carey LA, Bernard PS, Nielsen TO, Perou CM, Ellis MJ, Barry WT.

NPJ Breast Cancer. 2016;2. pii: 15023. doi: 10.1038/npjbcancer.2015.23. Epub 2016 Jan 6.

3.

Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer.

Krop IE, Suter TM, Dang CT, Dirix L, Romieu G, Zamagni C, Citron ML, Campone M, Xu N, Smitt M, Gianni L.

J Clin Oncol. 2015 Apr 1;33(10):1136-42. doi: 10.1200/JCO.2014.58.7782. Epub 2015 Feb 23.

4.

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

Prat A, Lluch A, Albanell J, Barry WT, Fan C, Chacón JI, Parker JS, Calvo L, Plazaola A, Arcusa A, Seguí-Palmer MA, Burgues O, Ribelles N, Rodriguez-Lescure A, Guerrero A, Ruiz-Borrego M, Munarriz B, López JA, Adamo B, Cheang MC, Li Y, Hu Z, Gulley ML, Vidal MJ, Pitcher BN, Liu MC, Citron ML, Ellis MJ, Mardis E, Vickery T, Hudis CA, Winer EP, Carey LA, Caballero R, Carrasco E, Martín M, Perou CM, Alba E.

Br J Cancer. 2014 Oct 14;111(8):1532-41. doi: 10.1038/bjc.2014.444. Epub 2014 Aug 7.

5.

Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?

Hudis CA, Citron ML, Muss H, Norton L, Winer EP.

J Clin Oncol. 2012 Sep 1;30(25):3148-9; author reply 3149-50. doi: 10.1200/JCO.2012.43.4746. Epub 2012 Jul 30. No abstract available.

PMID:
22851555
6.

Isolated sternal involvement in breast cancer: is it truly stage IV disease?

Chockalingam P, Astrow AB, Klein P, Huang Y, Reichman BS, Citron ML.

Clin Breast Cancer. 2011 Jun;11(3):191-4. doi: 10.1016/j.clbc.2011.03.017. Epub 2011 May 3.

PMID:
21665140
7.

Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives.

Citron ML.

Breast Care (Basel). 2008;3(4):251-255. Epub 2008 Aug 20.

8.

Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.

Muss HB, Berry DA, Cirrincione C, Budman DR, Henderson IC, Citron ML, Norton L, Winer EP, Hudis CA; Cancer and Leukemia Group B Experience.

J Clin Oncol. 2007 Aug 20;25(24):3699-704.

PMID:
17704418
9.

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP.

JAMA. 2006 Apr 12;295(14):1658-67. Erratum in: JAMA. 2006 May 24;295(20):2356.

10.

Dose-dense chemotherapy for node-positive breast cancer.

Citron ML.

Ann Intern Med. 2005 Feb 1;142(3):227. No abstract available.

PMID:
15684219
11.

Dose density in adjuvant chemotherapy for breast cancer.

Citron ML.

Cancer Invest. 2004;22(4):555-68. Review.

PMID:
15565814
12.

Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study.

Mucci-LoRusso P, Berman BS, Silberstein PT, Citron ML, Bressler L, Weinstein SM, Kaiko RF, Buckley BJ, Reder RF.

Eur J Pain. 1998;2(3):239-49.

PMID:
15102384
13.

Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York.

Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1474-8.

14.

Lung cancer risk in white and black Americans.

Stellman SD, Chen Y, Muscat JE, Djordjevic MV, Richie JP Jr, Lazarus P, Thompson S, Altorki N, Berwick M, Citron ML, Harlap S, Kaur TB, Neugut AI, Olson S, Travaline JM, Witorsch P, Zhang ZF.

Ann Epidemiol. 2003 Apr;13(4):294-302.

PMID:
12684197
15.

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L.

J Clin Oncol. 2003 Apr 15;21(8):1431-9. Epub 2003 Feb 13. Erratum in: J Clin Oncol. 2003 Jun 1;21(11):2226.

PMID:
12668651
16.

Smoking and lung cancer risk in American and Japanese men: an international case-control study.

Stellman SD, Takezaki T, Wang L, Chen Y, Citron ML, Djordjevic MV, Harlap S, Muscat JE, Neugut AI, Wynder EL, Ogawa H, Tajima K, Aoki K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1193-9.

17.

Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York.

Stellman SD, Djordjevic MV, Britton JA, Muscat JE, Citron ML, Kemeny M, Busch E, Gong L.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1241-9.

18.

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.

Citron ML, Kaplan R, Parris WC, Croghan MK, Herbst LH, Rosenbluth RJ, Reder RF, Slagle NS, Buckley BJ, Kaiko RF.

Cancer Invest. 1998;16(8):562-71.

PMID:
9844616
19.

Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.

Kaplan R, Parris WC, Citron ML, Zhukovsky D, Reder RF, Buckley BJ, Kaiko RF.

J Clin Oncol. 1998 Oct;16(10):3230-7.

PMID:
9779696
20.

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.

Fetting JH, Gray R, Fairclough DL, Smith TJ, Margolin KA, Citron ML, Grove-Conrad M, Cella D, Pandya K, Robert N, Henderson IC, Osborne CK, Abeloff MD.

J Clin Oncol. 1998 Jul;16(7):2382-91.

PMID:
9667255
21.

Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York.

Stellman SD, Djordjevic MV, Muscat JE, Gong L, Bernstein D, Citron ML, White A, Kemeny M, Busch E, Nafziger AN.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):489-96.

22.

Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.

Yogelzang NJ, Herndon JE 2nd, Cirrincione C, Harmon DC, Antman KH, Corson JM, Suzuki Y, Citron ML, Green MR.

Cancer. 1997 Jun 1;79(11):2237-42.

PMID:
9179072
23.

Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase.

Belanich M, Randall T, Pastor MA, Kibitel JT, Alas LG, Dolan ME, Schold SC Jr, Gander M, Lejeune FJ, Li BF, White AB, Wasserman P, Citron ML, Yarosh DB.

Cancer Chemother Pharmacol. 1996;37(6):547-55.

PMID:
8612308
24.

Adjuvant therapy for breast cancer.

Budman DR, Citron ML.

Clin Obstet Gynecol. 1994 Dec;37(4):978-87. Review. No abstract available.

PMID:
7842566
25.

Assessment of chlorinated pesticides and polychlorinated biphenyls in adipose breast tissue using a supercritical fluid extraction method.

Djordjevic MV, Hoffmann D, Fan J, Prokopczyk B, Citron ML, Stellman SD.

Carcinogenesis. 1994 Nov;15(11):2581-5.

PMID:
7955109
26.

5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin.

Stein TA, Burns GP, Bailey B, Citron ML.

Cancer Invest. 1994;12(4):375-8.

PMID:
8032956
27.

Analysis of O6-methylguanine-DNA methyltransferase in individual human cells by quantitative immunofluorescence microscopy.

Belanich M, Ayi TC, Li BF, Kibitel JT, Grob DW, Randall T, White AB, Citron ML, Yarosh DB.

Oncol Res. 1994;6(3):129-37.

PMID:
7994084
28.

Placebos and principles: a trial of ondansetron.

Citron ML.

Ann Intern Med. 1993 Mar 15;118(6):470-1. No abstract available.

PMID:
8439123
29.

A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma.

Whitehead RP, Figlin R, Citron ML, Pfile J, Moldawer N, Patel D, Jones G, Levitt D, Zeffren J.

J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):117-21.

PMID:
8318496
30.

Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use.

Citron ML, Kalra JM, Seltzer VL, Chen S, Hoffman M, Walczak MB.

Cancer Invest. 1992;10(5):335-41.

PMID:
1393684
31.
32.

Continuous intravenous infusion of morphine for severe dyspnea.

Cohen MH, Anderson AJ, Krasnow SH, Spagnolo SV, Citron ML, Payne M, Fossieck BE Jr.

South Med J. 1991 Feb;84(2):229-34.

PMID:
1899295
33.

Thrombosis: the major Hickman catheter complication in patients with solid tumor.

Anderson AJ, Krasnow SH, Boyer MW, Cutler DJ, Jones BD, Citron ML, Ortega LG, Cohen MH.

Chest. 1989 Jan;95(1):71-5.

PMID:
2909358
34.

Lung cancer, tuberculin reactivity, and isoniazid.

Alhashimi MM, Citron ML, Fossieck BE Jr, Steinberg SM, Johnston-Early A, Krasnow SH, Cohen MH.

South Med J. 1988 Mar;81(3):337-40.

PMID:
2831628
35.

Clearance of continuous intravenous morphine for severe cancer pain.

Citron ML, Reynolds JR, Lin WN, Frade PD, Schemansky M, Cohen MH, Krasnow SH, Johnston-Anderson A, Seltzer VL.

Drug Intell Clin Pharm. 1987 Dec;21(12):981-5.

PMID:
3428164
36.

Unusual opioid withdrawal syndrome.

Citron ML, Turchin L, Horowitz S, Fleishman S.

Lancet. 1987 May 30;1(8544):1271. No abstract available.

PMID:
2884407
37.

Intramedullary spinal cord metastases treated by complete resection of tumor prior to radiotherapy and chemotherapy. Case report and review.

Decker RE, Sundrani S, Citron ML, Herrschaft DS.

Spine (Phila Pa 1976). 1987 May;12(4):393-5. No abstract available.

PMID:
3616755
38.

Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.

Citron ML, Reynolds JR, Kalra J, Kay BG, Nathan KA, Jaffe ND, Miller FR.

Cancer Treat Rep. 1987 Mar;71(3):317-9.

PMID:
3815397
39.

Improvement of human tumor cloning assay by suspension of fibroblasts into the bottom layer of agarose.

Citron ML, Jaffe ND, Hamburger AW, Lindblad AL, Banda FP, Yenson A, Nathan KA, Cohen MH.

Cancer. 1986 Jun 15;57(12):2357-62.

PMID:
3697935
40.

Patient-controlled analgesia for severe cancer pain.

Citron ML, Johnston-Early A, Boyer M, Krasnow SH, Hood M, Cohen MH.

Arch Intern Med. 1986 Apr;146(4):734-6.

PMID:
2421659
42.

Drug precipitation within i.v. tubing: a potential hazard of chemotherapy administration.

Cohen MH, Johnston-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.

Cancer Treat Rep. 1985 Nov;69(11):1325-6.

PMID:
4092196
43.

Hickman catheter tip displacement.

Krasnow SH, Rhodes G, Boyer M, Citron ML, Gaspar O, Johnston-Early A, Cohen MH.

South Med J. 1985 Nov;78(11):1327-9.

PMID:
3906910
44.

Local toxicity from iv administration of Baker's antifol.

Krasnow SH, Patterson RH, Fischmann B, Eisenberger MA, Johnston-Early A, Citron ML, Cohen MH.

Cancer Treat Rep. 1985 Jun;69(6):735-6. No abstract available.

PMID:
4016783
45.

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.

Citron ML, Herman TS, Vreeland F, Krasnow SH, Fossieck BE Jr, Harwood S, Franklin R, Cohen MH.

Cancer Treat Rep. 1985 Jan;69(1):109-12.

PMID:
2981616
46.

Safety and efficacy of continuous intravenous morphine for severe cancer pain.

Citron ML, Johnston-Early A, Fossieck BE Jr, Krasnow SH, Franklin R, Spagnolo SV, Cohen MH.

Am J Med. 1984 Aug;77(2):199-204.

PMID:
6205587
47.

Combined therapy for stage III-IV head and neck cancer: preliminary results.

Krasnow SH, Cohen MH, Johnston-Early A, Citron ML, Fossieck BE Jr, Mauk CM, Yenson A, Banda FP, Lunzer S, deFries HO.

J Clin Oncol. 1984 Jul;2(7):804-10.

PMID:
6737021
48.

An active chemotherapy regimen for squamous cell lung cancer.

Cohen MH, Johnston-Early A, Citron ML, Krasnow SH, Fossieck BE Jr.

Cancer Treat Rep. 1984 Mar;68(3):475-9.

PMID:
6200219
49.

Tumor seeding associated with bone marrow aspiration and biopsy.

Citron ML, Krasnow SH, Grant C, Cohen MH.

Arch Intern Med. 1984 Jan;144(1):177.

PMID:
6318678
50.

Modulation of human tumor colony growth in soft agar by serum.

Hamburger AW, White CP, Dunn FE, Citron ML, Hummel S.

Int J Cell Cloning. 1983 Sep;1(4):216-29.

PMID:
6366083

Supplemental Content

Loading ...
Support Center